No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY

Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on lopinavir-ritonavir, 29 June 2020 In March 2020, the RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments […]

Click here to view original web page at No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY